Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes ...

Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature ...

Vivani Medical (VANI) and Okava Pharmaceuticals announced an expansion of their collaboration to include dogs in the development of OKV-119, a ...

Over half of all dogs in the United States today are overweight or obese, placing them at increased risk for chronic diseases ...

The United States stock market has recently experienced significant volatility, with major indices like the Dow Jones and Nasdaq seeing sharp declines amid ongoing economic uncertainties and ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Vivani Medical, Inc. (VANI) on Monday reported a loss of $6.1 million in its fourth quarter. On a per-share basis, the Alameda, California-based ...

ALAMEDA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, ultra long-acting drug ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Vivani Medical, Inc. (VANI) on Monday reported a loss of $6.1 million in its fourth quarter. On a per-share basis, the Alameda, California-based company ...